ISHARES GLOBAL HEALTHCARE ETF - Common Stock (IXJ) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
IXJ
Shares outstanding
43,358,356
Price per share
$97.40
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
32,360,095
Total reported value
$2,869,228,016
% of total 13F portfolios
0%
Share change
+150,297
Value change
+$13,478,114
Number of holders
258
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ISHARES GLOBAL HEALTHCARE ETF - Common Stock (IXJ) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 22% -5.8% $862,885,474 -$21,695,900 9,755,630 -2.5% BlackRock, Inc. 31 Mar 2025
BlackRock Portfolio Management LLC 10% $374,950,518 4,239,124 BlackRock Portfolio Management LLC 31 Jan 2025

As of 30 Sep 2025, 258 institutional investors reported holding 32,360,095 shares of ISHARES GLOBAL HEALTHCARE ETF - Common Stock (IXJ). This represents 75% of the company’s total 43,358,356 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of ISHARES GLOBAL HEALTHCARE ETF - Common Stock (IXJ) together control 71% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 32% 13,960,370 -0.66% 0.02% $1,237,167,989
Fisher Asset Management, LLC 17% 7,439,921 +7.8% 0.24% $659,325,869
BANK OF AMERICA CORP /DE/ 5.5% 2,396,053 -5.7% 0.02% $212,338,260
Richard Bernstein Advisors LLC 3% 1,308,385 -3% 3.3% $117,352,821
Phoenix Financial Ltd. 2.8% 1,199,280 -0% 1.3% $106,280,194
AMERIPRISE FINANCIAL INC 2% 875,680 -4.3% 0.02% $77,614,231
JPMORGAN CHASE & CO 1.1% 496,862 -5.6% 0% $44,031,970
MORGAN STANLEY 1% 438,207 -16% 0% $38,833,980
Federation des caisses Desjardins du Quebec 0.68% 292,985 -7% 0.1% $25,964,236
UBS Group AG 0.61% 266,199 -3.3% 0% $23,590,555
ROYAL BANK OF CANADA 0.58% 250,335 -9.3% 0% $22,184,000
ENVESTNET ASSET MANAGEMENT INC 0.55% 236,511 -0.31% 0.01% $20,959,608
WELLS FARGO & COMPANY/MN 0.49% 212,102 -3.3% 0% $18,796,493
RAYMOND JAMES FINANCIAL INC 0.36% 154,865 +1.2% 0% $13,724,128
LPL Financial LLC 0.33% 142,398 +9.1% 0% $12,619,317
HighTower Advisors, LLC 0.32% 137,560 +4.9% 0.01% $12,190,674
BARCLAYS PLC 0.27% 115,760 0% 0% $10,258,651
BANK OF MONTREAL /CAN/ 0.24% 103,788 +9.8% 0% $9,197,693
JANE STREET GROUP, LLC 0.23% 100,628 +133% 0.01% $8,917,653
Leo Wealth, LLC 0.21% 92,282 -34% 1.1% $8,178,073
COMMONWEALTH EQUITY SERVICES, LLC 0.21% 89,603 +4.6% 0.01% $7,941,000
BNP PARIBAS FINANCIAL MARKETS 0.2% 87,969 0% 0.01% $7,795,813
Robertson Stephens Wealth Management, LLC 0.16% 69,316 0.19% $6,142,784
Equitable Holdings, Inc. 0.16% 68,336 -20% 0.04% $6,055,936
Banco Santander, S.A. 0.14% 62,536 -5.6% 0.05% $5,541,940

Institutional Holders of ISHARES GLOBAL HEALTHCARE ETF - Common Stock (IXJ) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 185,992 $18,123,460 +$8,612,994 $97.40 20
2025 Q3 32,360,095 $2,869,228,016 +$13,478,114 $88.62 258
2025 Q2 32,293,426 $2,780,167,010 +$40,139,362 $86.09 268
2025 Q1 31,806,997 $2,900,921,711 +$92,094,642 $91.20 263
2024 Q4 30,858,526 $2,653,109,314 -$57,455,698 $85.97 275
2024 Q3 31,484,488 $3,090,109,773 -$43,741,774 $98.16 271
2024 Q2 31,630,868 $2,936,436,825 -$41,080,091 $92.84 270
2024 Q1 32,018,117 $2,982,405,553 -$28,348,865 $93.15 262
2023 Q4 32,234,110 $2,808,087,818 -$115,286,480 $86.72 256
2023 Q3 33,531,267 $2,762,901,880 +$125,681,855 $82.42 265
2023 Q2 32,016,825 $2,721,053,651 -$137,908,283 $84.99 266
2023 Q1 33,610,588 $2,801,885,706 -$134,848,382 $83.36 250
2022 Q4 35,245,238 $2,991,615,667 +$562,472,072 $84.88 266
2022 Q3 28,907,284 $2,178,671,414 +$178,612,473 $75.35 228
2022 Q2 26,533,915 $2,153,005,536 +$151,886,282 $81.14 235
2022 Q1 24,641,964 $2,158,899,312 -$80,898,249 $87.62 227
2021 Q4 25,565,354 $2,310,021,165 +$88,304,396 $90.34 230
2021 Q3 24,228,434 $2,028,729,171 +$56,237,608 $83.73 213
2021 Q2 23,534,360 $1,956,237,483 +$129,520,056 $83.12 208
2021 Q1 22,010,917 $1,696,414,990 +$209,758,232 $77.06 202
2020 Q4 19,275,712 $1,473,674,936 +$71,680,789 $76.45 206
2020 Q3 18,378,162 $1,319,666,891 +$32,353,357 $71.82 195
2020 Q2 17,918,575 $1,232,551,946 -$48,835,147 $68.78 197
2020 Q1 18,655,367 $1,137,077,815 +$3,162,360 $60.94 198
2019 Q4 18,582,534 $1,275,652,491 +$16,124,454 $68.75 213
2019 Q3 18,190,714 $1,111,182,265 -$230,361,135 $61.09 184
2019 Q2 21,959,087 $1,354,931,490 +$89,473,093 $61.71 189
2019 Q1 20,508,108 $1,252,935,958 +$296,101,530 $61.10 200
2018 Q4 15,755,323 $892,473,598 +$71,046,943 $56.65 202
2018 Q3 14,370,546 $904,982,750 +$470,051,390 $62.98 181
2018 Q2 6,854,664 $386,908,371 +$174,743,577 $56.44 162
2018 Q1 3,746,303 $416,827,395 -$51,325,739 $111.33 158
2017 Q4 4,222,051 $475,069,443 +$21,105,753 $112.53 157
2017 Q3 3,974,741 $446,934,406 -$47,484,681 $112.46 146
2017 Q2 4,390,923 $480,198,779 +$15,681,250 $109.35 141
2017 Q1 4,258,542 $437,699,223 +$5,709,776 $102.79 139
2016 Q4 4,174,555 $396,062,614 -$80,487,121 $94.83 135
2016 Q3 4,981,364 $501,603,086 -$31,600,213 $100.73 140
2016 Q2 5,293,097 $534,699,009 -$10,514,205 $100.99 139
2016 Q1 5,384,279 $518,583,180 +$149,654,954 $96.30 125
2015 Q4 3,834,216 $393,011,459 -$135,030,413 $102.62 134
2015 Q3 5,134,665 $505,955,151 +$39,546,887 $98.48 128
2015 Q2 4,726,069 $513,906,882 -$85,347,769 $108.72 134
2015 Q1 5,523,967 $595,531,893 +$139,719,877 $107.81 132
2014 Q4 4,267,627 $424,961,028 +$131,569,312 $99.56 125
2014 Q3 2,882,951 $281,588,205 -$9,985,920 $97.70 101
2014 Q2 2,977,149 $280,825,504 -$14,985,241 $94.33 106
2014 Q1 3,141,019 $285,986,926 +$9,552,068 $91.06 108